Lemaitre Vascular (LMAT) Retained Earnings (2010 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Retained Earnings of $194.7 million for Q1 2026, up 3878.05% year-over-year from $4.9 million in Q1 2025, and up 5.4% quarter-over-quarter from $184.7 million in Q4 2025.
Lemaitre Vascular (LMAT) Retained Earnings (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Retained Earnings for 17 consecutive years, with $194.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings rose 3878.05% year-over-year to $194.7 million; the TTM figure through Mar 2026 stood at $194.7 million (up 3878.05% YoY), while the FY2025 annual figure was $184.7 million, up 27.31% from the prior year.
- Retained Earnings improved to $194.7 million in Q1 2026 per LMAT's latest filing, from $184.7 million in the prior quarter.
- Across five years, Retained Earnings topped out at $194.7 million in Q1 2026 and bottomed at -$8.1 million in Q3 2022.
- Historically, Retained Earnings has averaged $75.9 million across 5 years, with a median of $97.8 million in 2022.
- Annual changes were most pronounced in 2022 — Retained Earnings slumped 208.31% — and 2026, when it surged 3878.05%.
- Lemaitre Vascular's Retained Earnings stood at $97.8 million in 2022, then climbed by 18.06% to $115.4 million in 2023, then climbed by 25.7% to $145.1 million in 2024, then climbed by 27.31% to $184.7 million in 2025, then gained by 5.4% to $194.7 million in 2026.
- Business Quant data shows LMAT's Retained Earnings at $194.7 million in Q1 2026, $184.7 million in Q4 2025, and -$2.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 6.84 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 17.51 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 7.26 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 11.40 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.62 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 3.92 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 7.70 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 13.81 Bn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn | 206.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 206.02 Mn |
| Mar 31, 2026 | 194.68 Mn |
| Dec 31, 2025 | 184.72 Mn |
| Sep 30, 2025 | -2.91 Mn |
| Jun 30, 2025 | 160.84 Mn |
| Mar 31, 2025 | -5.15 Mn |
| Dec 31, 2024 | 145.09 Mn |
| Sep 30, 2024 | -3.16 Mn |
| Jun 30, 2024 | -5.09 Mn |
| Mar 31, 2024 | 121.73 Mn |
| Dec 31, 2023 | 115.43 Mn |
| Sep 30, 2023 | 110.08 Mn |
| Jun 30, 2023 | 105.70 Mn |
| Mar 31, 2023 | -5.57 Mn |
| Dec 31, 2022 | 97.77 Mn |
| Sep 30, 2022 | -8.13 Mn |
| Jun 30, 2022 | -6.44 Mn |
| Mar 31, 2022 | 91.42 Mn |
| Dec 31, 2021 | -3.44 Mn |
| Sep 30, 2021 | -2.64 Mn |